α-Spinasterol

Synonyms: 菠甾醇
α-Spinasterol 是一种可口服的瞬时受体电位香草酸1(TRPV1)拮抗剂,同时也是 COX-1 和 COX-2 的抑制剂(IC50 值分别为 16.17 μM 和 7.76 μM),具有抗菌、抗炎、抗抑郁、抗氧化和抗伤害作用,可透过血脑屏障,并能改善小鼠糖尿病。
产品编号: MS-J85439 纯度: 99.90% CAS No.: 481-18-5 分子式: C29H48O 分子量: 412.69
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价

产品描述

α-Spinasterol 是一种可口服的瞬时受体电位香草酸1(TRPV1)拮抗剂,同时也是 COX-1 和 COX-2 的抑制剂(IC50 值分别为 16.17 μM 和 7.76 μM),具有抗菌、抗炎、抗抑郁、抗氧化和抗伤害作用,可透过血脑屏障,并能改善小鼠糖尿病。

生物实验数据

生物活性 α-Spinasterol is an orally available transient receptor potential vanilloid 1 (TRPV1) antagonist and an inhibitor of COX-1 and COX-2 with IC50 values of 16.17 μM and 7.76 μM, respectively, and it exhibits antibacterial, anti-inflammatory, antidepressant, antioxidant, and antinociceptive activities, is capable of crossing the blood-brain barrier, and can ameliorate diabetes in mice.
IC50 & Target COX-1:16.17 μM (IC50), COX-2:7.76 μM (IC50)
体外研究
(In Vitro)

α-Spinasterol 有抑菌活性,对 E.coli,S.pneumaniae CAU0070,S.pullorum cvcc533,S.areus 的 MIC 为 0.13,0.24,1.92,3.69 nM。
α-Spinastero 与头孢替福联用,抗菌效果更好。
α-Spinasterol (0-0.5 ng/mL,24 h) 对肾小球系膜细胞 GMCs 具有抑制作用,IC50 为 3.9×10-12 g/mL。

Cell Viability Assay

Cell Line: E.coli, S.pneumaniae CAU0070, S.pullorum cvcc533, S.areus
Concentration: 1/8 MIC
Incubation Time: 0, 2, 4, 6, 8, 12, 24 h
Result: Suppressed all four types of bacteria, and after being exposed for 24 hours, Staphylococcus aureus could be killed, leading to a sharp decline in bacterial numbers.

Cell Viability Assay

Cell Line: GMCs
Concentration: 0 and 0.5 ng/mL
Incubation Time: 24 h
Result: Suppressed cell proliferation.
体内研究
(In Vivo)

α-Spinasterol (0.5-2.5 mg/kg,口服,6 周) 降低了小鼠血清甘油三酯,改善糖尿病症状。
α-Spinasterol (0.1-1 mg/kg,口服,24 h) 在小鼠术后和神经性疼痛模型中具有抗伤害性作用。
α-Spinasterol (0-2 mg/kg,i.p.,单次剂量) 在小鼠中有抗抑郁作用,但没有抗焦虑作用。
α-Spinasterol (0.001-10 mg/kg,i.g.,单次剂量) 显著减少 LPS (MS-X54539) 诱导的小鼠的炎症细胞浸润。
α-Spinasterol (0.001-1 mg/kg,i.p.,单次剂量) 可抑制小鼠白细胞和单个核细胞,ID50为 0.006 (0.002-0.01) mg/kg和 0.004 (0.002-0.007) mg/kg。
α-Spinasterol (0.001-1 mg/kg,i.p.,单次剂量) 对小鼠有抗惊厥活性,且不影响小鼠的神经肌肉力量,不损害运动协调,不改变体温。

Animal Model: Streptozotocin-induced diabetic mice
Dosage: 0.5 and 2.5 mg/kg/day; 6 weeks
Administration: Oral
Result: Reduced serum triglycerides in mice, kidney weight, and urinary protein excretion, without affecting serum glucose levels.
Animal Model: Mouse postoperative pain models (surgery incision induced) or different neuropathic pain models (trauma or chemotherapy induced)
Dosage: 0.1, 0.3, 1 mg/kg; 24 h
Administration: Oral
Result: Relieved post-operative pain, reduce cell infiltration in damaged tissues, alleviated some mechanical ectopic pain caused by sciatic nerve ligation and mechanical and cold ectopic pain induced by paclitaxel, without altering spontaneous or forced motor activity, causing gastric damage, or leading to changes in the liver and kidneys, and without affecting the cell viability in mouse cortical and spinal cord slices.
Inhibited COX-1 and COX-2 enzyme activity without altering the animal's body temperature.
Animal Model: Naïve male Albino Swiss mice
Dosage: 0, 0.5, 1, 2 mg/kg; 0.5-2 mg/kg; single dose
Administration: Intraperitoneal injection (i.p.)
Result: Showed an anti-immobility effect in the forced swimming test on mice, with no significant changes in body temperature and no alteration in the mice's spontaneous movement activity. Showed no anti-anxiety effects in the elevated plus maze and light-dark box tests.
Animal Model: LPS(MS-X54539)-induced peritonitis in mice
Dosage: 0.001-1 mg/kg; 1-10 mg/kg; single dose
Administration: i.g.
Result: Reduced inflammatory cell infiltration in LPS-injected mice.
Animal Model: Mice induced by PTZ;Mice induced by 6 Hz
Dosage: 0, 0.02, 0.1, 0.5, 1 mg/kg; single dose
Administration: Intraperitoneal injection (i.p.)
Result: Showed higher doses of 0.5 and 1 mg/kg significantly increased the threshold for chronic seizures without affecting the sensitivity of mice to the forelimb rigidity induced by PTZ. The CS50 values in the 0.5 mg/kg and 1 mg/kg groups were significantly increased. Did not affect the neuromuscular strength of the mice, did not impair motor coordination, and did not change the body temperature.
性状 固体
颜色 White to off-white

化学信息

分子量 412.69
分子式 C29H48O
CAS No. 481-18-5
别名 菠甾醇

储存&溶解度

储存方式

4°C, protect from light

*In solvent: -80°C, 6 months; -20°C, 1 month (protect from light)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMF 中的溶解度 : 2 mg/mL (4.85 mM; 超声助溶 (<60°C))

可选溶剂浓度1 mg5 mg10 mg25 mg
DMF1 mM2.4231 mL12.1156 mL24.2313 mL60.5782 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础